© 2008 DMPC www.dismgmt.comwww.dismgmt.com Promoting Transparency in Medicaid Chronic Care Outcomes June 2008.

Slides:



Advertisements
Similar presentations
ROI measurement: Finding the Fallacies. ROI How ROI is calculated Some examples of what ROIs are How to know when it is calculated wrong, as it usually.
Advertisements

Is the Predictive Modeling Industry Reflecting What We Now Know about Healthcare? Debunking Common Myths Monday, September 22, 2008 National Predictive.
The ACA and Its Impact on Persons with Disabilities: Jean P. Hall, PhD University of Kansas NASHP Conference October 4, 2011 Kansas City,
Context and Overview of Recommended Actions to Reduce Psychiatric Readmissions Michael Trangle, MD Associate Medical Director, Behavioral Health Division.
Its about the Region Its about the Community Its about our Friends and Neighbors.
Nurse Health Coaching. 2 What is Nurse Health Coaching? Nurse Health Coaching is a program that can help people with health conditions control their disease.
102903KeenanDMSummit:swh-1 Disease Management Programs Health Care Summit October 29, 2003 Caring is Good. Doing Something is Better. Sam Ho, M.D. SVP,
The Future of Disease Management May Agenda History of disease management Don’t drink the Kool-Aid: Why the “let’s do DM” model has not lived.
Using AHRQ Prevention Quality Indicators to Assess Program Performance in Medicaid Managed Care Sandra K. Mahkorn MD, MPH, MS Chief Medical Officer Wisconsin.
Don’t Be Afraid of ICD-10 Melonie Loutsch, CPC, ACS-EM April 26 th 2014.
SEHCB Educational and Training Conference Alere March 3, 2009 Columbus, OH.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
Disease Management in the Private Sector (2002) Al Lewis Executive Director Disease Management Purchasing Consortium LLC
Present on Admission. Requirements of Deficit Reduction Act 2005 CMS and CDC choose conditions that are: High Cost, High Volume, or both. Assigned to.
MAMSI Health Plans 2003 (c)1 Evaluating Disease Management Return on Investment “Lessons Learned” Sally J. Duran Disease Management Summit May 11, 2003.
Prior Authorizations (PAs, Prior Auth) Types of Medicaid “Extra Help”
© Disease Management Purchasing Consortium International Inc Disease Management Outcomes Gimme Three Steps, Gimme.
© Disease Management Purchasing Consortium International Inc Disease Management Outcomes How to Ensure Validity…
Critical Outcomes Report Analysis (CORA) Training: Spotting the errors May 2009.
How to Use Your CVUSD Health Benefits Effectively.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
The BIPA Disease Management Demo Project: Improving Outcomes For Medicare Beneficiaries Prepared for: Disease Management Colloquium June 29, 2004 The BIPA.
Harnessing the Power of Predictive Modeling Future Trends.
The (ex) Policy Maker’s View Chris Ham 31 March 2005.
© copyright 2004 American Healthways 1 The Role of Disease Management in the Private Sector The Disease Management Colloquium, Philadelphia, PA 1 p.m.
Value Based Insurance Design Michael Chernew Oct 10, 2008 Portions of this research were funded by Pfizer and GSK.
DataBrief: Did you know… DataBrief Series ● February 2013 ● No. 36 Medicare Beneficiaries With Severe Mental Illness and Hospitalization Rates In 2010,
Critical Outcomes Report Analysis May Agenda Some Logistics Overview of why reports are wrong and how to fix them –This will help somewhat in reading.
1 TWO YEARS OF OUTCOMES FROM A COMPREHENSIVE DM PROGRAM IN COMMERCIAL AND MEDICARE HEALTH PLAN MEMBERS Esther J. Nash, MD, Senior Medical Director, Population.
Ambulatory Care Quality Measures: Disease Management Research Opportunities Neil Goldfarb Director of Research and Research Assistant Professor of Health.
ICD-10 Transition September Modern History of ICD-10  The World Health Organization’s (WHO) International Classification of Diseases has served.
Washington State Medical Assistance Administration Disease Management Program Alice Lind, RN, MPH June 2004.
P4P as a Support Tool for Medicaid Disease Management Programs Jim Hardy President, Sellers-Feinberg.
© 2008 DMPC Inc Population Health Outcomes Benchmarking How do you compare? Are your programs working? How can you get valid measurement with ingredients.
BlueCross BlueShield of Tennessee, Inc., an Independent Licensee of the BlueCross BlueShield Association. This document has been classified as public Information.
Click to edit Master subtitle style Aetna Behavioral Health Depression Initiatives June 2006.
Integrating Behavioral Health and Primary Care
How to Measure Outcomes in Disease Management May 2008 Al Lewis Disease Management Purchasing Consortium All slides © 2008 DMPC.
Do Interruptions in Medicaid Coverage Increase the Risk of Preventable Hospitalizations? Andrew B. Bindman,MD Arpita Chattapadhyay PhD Glenna Auerback,
Population Health and the NCM Care Transformation Collaborative of R.I. NANCY MAMO, MANAGING DIRECTOR, POPULATION HEALTH ANALYTICS, BCBSRI MAY 5, 2015.
Agenda 1:00 Overview of why reports are wrong and how to fix them. This will help somewhat in reading them and in contracting for DM but critical outcomes.
1 Factors that Influence Hospitalization for Chronic Medical Conditions P.O. Box · 3040 Cornwallis Road · Research Triangle Park, NC Phone:
1 Are Changing Rates of Admission for Chronic Medical Conditions Simply a Reflection of Changes in the Demographics, Health Status and Geographic Migration.
Disease-Specific Event Reduction “Plausibility Indicators” The reasons for widespread marketplace acceptance.
1 Measuring the effectiveness of wellness programs and demonstrating Return On Investment Joe San Filippo Chief Health Care Strategist Nationwide Better.
Medical Home Evaluations: Why They Can Fail, How to Structure Them Debbie Peikes, Ph.D. May 26, 2010 Webinar for the Medical Home Audioconference Series.
Oregon's Coordinated Care Organizations: First Year Expenditure and Utilization Authors: Neal Wallace, PhD, Peter Geissert, MPH 1, and K. John McConnell,
Effects of the State Children’s Health Insurance Program on Children with Chronic Health Conditions Amy J. Davidoff, Ph.D. Genevieve Kenney, Ph.D. Lisa.
Disease Management & Special Needs Plans May 11, 2006.
SOLUCIA, INC. 1 An Actuarial Perspective on Disease Management ROI Measurement May 10, 2006.
The Impact of Cost Sharing on Middle-Income Children AcademyHealth Annual Research Meeting June 2008 Amy M Lischko.
Effects of the State Children’s Health Insurance Program on Children with Chronic Health Conditions Amy J. Davidoff, Ph.D. Genevieve Kenney, Ph.D. Lisa.
The Health Status of Australia’s children Mortality and Morbidity.
Diabetes: 0–44 years Ranked comorbidity combinations Source: ABS Australian Health Survey 2011–12 (National Health Survey component) For people aged 0–44,
What Will it Take for DM to Demonstrate an ROI? Ariel Linden, DrPH, MS President, Linden Consulting Group
Nancy Mamo, Managing Director, Population Health Analytics, BCBSRI
Home Health Remote Patient Monitoring For Heart Failure
Michigan Data Collaborative Overview
About the Client Challenges
Bending the Cost Curve A Case for Integration.
Value of Pharmaceuticals in Managed Care Pharmacy
Updates to the MDC Dashboards and All-Payer Patients Lists Summer 2013
President, Linden Consulting Group
LHS – Care Team Value Sets
(c) 2008 DMPC Test Overview Answer each question by number by saying what’s wrong or indicating that it can be concluded, based on the.
Redmond Fire & Rescue Community Paramedicine
Jay Feldstein, DO, CMO AmeriHealth Mercy/Keystone Mercy Health Plan
From Theory to Practice Admission-based Outcomes September 7, 2006
Value of Pharmaceuticals in Managed Care Pharmacy
Presentation transcript:

© 2008 DMPC Promoting Transparency in Medicaid Chronic Care Outcomes June 2008

© 2008 DMPC Agenda How not to measure your chronic care disease management outcomes How to measure your chronic care disease management outcomes Examples

© 2008 DMPC How not to measure: In this example… …Assume that “trend” is already taken into account correctly Focus on the baseline and contract period comparison

© 2008 DMPC Base Case: Example from Asthma First asthmatic has a $1000 IP claim in (baseline) 2006 (contract) Asthmatic #11000 Asthmatic #2 Cost/asthmatic

© 2008 DMPC Example from Asthma Second asthmatic has an IP claim in 2006 while first asthmatic goes on drugs (common post-event) 2005 (baseline) 2006 (contract) Asthmatic # Asthmatic # Cost/asthmatic What is the Cost/asthmatic In the baseline?

© 2008 DMPC Cost/asthmatic in baseline? 2005 (baseline) 2006 (contract) Asthmatic # Asthmatic # Cost/asthmatic $1000 Vendors don’t count #2 in 2005 bec. he can’t be found

© 2008 DMPC Cost/asthmatic in contract period? 2005 (baseline) 2006 (contract) Asthmatic # Asthmatic # Cost/asthmatic $1000$550

© 2008 DMPC Why Pre-Post Overstates Savings 2005 (baseline) 2006 (contract) Asthmatic # Asthmatic # Cost/asthmatic $1000$550 In this case, a “dummy population” falls 45% on its own without DM due to the magic Of actuarial “black boxes”

© 2008 DMPC Agenda How not to measure your chronic care disease management outcomes How to measure your chronic care disease management outcomes Examples

© 2008 DMPC The Valid Way to Check Pre-Post Savings Claims –You look at the event rates overall in the plan (or in your own organization if large enough) over time As though you were measuring a birth rate. Very simple As in this example, count total IP (and ER) events, divide by 1000

© 2008 DMPC Asthma events in the state as a whole 2005 (baseline) 2006 (contract) Asthmatic # Asthmatic # Inpatient events/year 11 Actuarial method shows 45% savings Non-actuarial transparent approach shows no change in costs

© 2008 DMPC Let’s look at one state’s numbers These are simply the ER and IP events primary-coded for the disease in question These events are exactly what you are trying to avoid through DM (chronic burden * poor management = ER and IP usage by ICD9 code) –Over time –Pre and post disease management

© 2008 DMPC Agenda How not to measure your chronic care disease management outcomes How to measure your chronic care disease management outcomes Examples

© 2008 DMPC Trends in total admissions/ER visits prior to DM (disabled population)

© 2008 DMPC Trends in total admissions/ER visits following DM (thick lines)

© 2008 DMPC Implications of this simple analysis DM is working modestly well for CHF but not for CAD, asthma or diabetes COPD needs a program! You can easily move from these reductions to an ROI using a “number needed to decrease” spreadsheet (on request) Let’s see how one plan compares to other plans (not enough comparisons For states in the database…yet)

© 2008 DMPC Incidence Rate Per 1,000 Members Asthma Rates Pre DM Partial DM Full DM Example: total asthma events across health plans (not states – not enough data yet)

© 2008 DMPC What did this slide show? Plan 5 has a very successful asthma program (assume that age profiles of these plans are similar) The other plans instituted asthma programs and failed to show actual savings despite giddy pre-post reports claiming ROIs.

© 2008 DMPC What are the implications for states of this simple transparent analysis? You can compare yourselves to other states –Chronic disease burden * how badly it is managed = “failure rate” – ER and IP use You can now compare your health plans to one another…and to history –You can actually determine if they are accomplishing anything other than squeezing providers and denying care